MX229299B - Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion - Google Patents

Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion

Info

Publication number
MX229299B
MX229299B MXPA01004873A MX229299B MX 229299 B MX229299 B MX 229299B MX PA01004873 A MXPA01004873 A MX PA01004873A MX 229299 B MX229299 B MX 229299B
Authority
MX
Mexico
Prior art keywords
mouth
preparation process
dose forms
mixture
dosage forms
Prior art date
Application number
Other languages
English (en)
Inventor
Claude Laruelle
No L Zakarian
Rene Gimet
Dominique Toselli
Original Assignee
Cll Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cll Pharma filed Critical Cll Pharma
Publication of MXPA01004873A publication Critical patent/MXPA01004873A/es
Publication of MX229299B publication Critical patent/MX229299B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA/A/2001/004873 1999-09-15 2000-09-15 Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion MX229299B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9911513A FR2798289B1 (fr) 1999-09-15 1999-09-15 Formes galeniques a delitement rapide en bouche et leur procede de preparation
FR99/11513 1999-09-15
PCT/FR2000/002563 WO2001019336A1 (fr) 1999-09-15 2000-09-15 Formes galeniques a delitement rapide en bouche et leur procede de preparation

Publications (2)

Publication Number Publication Date
MXPA01004873A MXPA01004873A (es) 2002-06-05
MX229299B true MX229299B (es) 2005-07-20

Family

ID=9549849

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA/A/2001/004873 MX229299B (es) 1999-09-15 2000-09-15 Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion

Country Status (18)

Country Link
US (1) US6669957B1 (es)
EP (1) EP1131050B8 (es)
JP (1) JP2003509353A (es)
KR (1) KR100854033B1 (es)
AT (1) ATE267581T1 (es)
AU (1) AU7526300A (es)
BR (1) BR0007151A (es)
CA (1) CA2350675A1 (es)
DE (1) DE60011036T2 (es)
ES (1) ES2222234T3 (es)
FR (1) FR2798289B1 (es)
HU (1) HUP0104914A3 (es)
MA (1) MA25323A1 (es)
MX (1) MX229299B (es)
PL (1) PL200672B1 (es)
PT (1) PT1131050E (es)
WO (1) WO2001019336A1 (es)
ZA (1) ZA200103280B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US20050220874A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
US20050220873A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US20050226927A1 (en) * 2004-04-02 2005-10-13 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
JP5112619B2 (ja) * 2004-05-20 2013-01-09 大塚製薬株式会社 固形医薬製剤
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CA2611418C (en) * 2005-06-08 2010-10-05 Basf Corporation Medicament carrier composition and method of forming a film therefrom
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
US20100310686A1 (en) * 2007-11-14 2010-12-09 Uxmal S.A., Chile Extracts of deschampsia antarctica desv, with antineoplastic activity
WO2010104563A2 (en) 2009-03-09 2010-09-16 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
US9101529B2 (en) * 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2015070396A1 (zh) * 2013-11-13 2015-05-21 财团法人国防教育研究基金会 无肝副作用的对乙酰胺基酚新复方组合
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
FR3099881B1 (fr) 2019-08-13 2022-08-26 Ethypharm Sa Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
DE69728857T3 (de) * 1996-02-09 2010-02-18 Quadrant Drug Delivery Ltd., Ruddington Feste arzneimittel enthaltend trehalose
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof

Also Published As

Publication number Publication date
ATE267581T1 (de) 2004-06-15
EP1131050A1 (fr) 2001-09-12
KR20010089883A (ko) 2001-10-12
AU7526300A (en) 2001-04-17
EP1131050B1 (fr) 2004-05-26
BR0007151A (pt) 2001-08-14
HUP0104914A3 (en) 2003-05-28
DE60011036D1 (de) 2004-07-01
MA25323A1 (fr) 2001-12-31
PT1131050E (pt) 2004-11-30
KR100854033B1 (ko) 2008-08-26
FR2798289A1 (fr) 2001-03-16
JP2003509353A (ja) 2003-03-11
PL200672B1 (pl) 2009-01-30
US6669957B1 (en) 2003-12-30
DE60011036T2 (de) 2005-06-23
ES2222234T3 (es) 2005-02-01
WO2001019336A1 (fr) 2001-03-22
PL347693A1 (en) 2002-04-22
CA2350675A1 (fr) 2001-03-22
ZA200103280B (en) 2001-10-25
HUP0104914A2 (hu) 2002-07-29
FR2798289B1 (fr) 2004-12-31
EP1131050B8 (fr) 2004-11-10

Similar Documents

Publication Publication Date Title
MX229299B (es) Formas de dosis farmaceuticas con desintegracion rapida en la boca y su proceso de preparacion
MY118371A (en) Tetrahydrolipstatin containing compositions
HUP0300530A2 (hu) Hidrofil/lipofil polimer mátrix adagolási kiszerelés
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
ATE435294T1 (de) Verabreichung von biologisch aktiven polypeptiden
ITRM930591A0 (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
NO20030897D0 (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
AR013117A1 (es) Una composicion farmaceutica solida en forma de comprimido que comprende un derivado de benzofurano con actividad antiarritmica adaptada para administracion oral
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
EP0350701A3 (en) Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes
MY127350A (en) Flash-melt oral dose formulations
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
WO2003049694A3 (en) Methods of therapy for non-hodgkin's lymphoma
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
MY136059A (en) Swallow tablet comprising paracetamol
MY106371A (en) Oral pharmaceutical compositions in unit dosage form
HUP0104476A2 (hu) Hidroxi-propil-mutil-cellulóz kapszulákban formázott gyógyszerkészítmények
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon

Legal Events

Date Code Title Description
FG Grant or registration